Pricing Log in Create free account

Better Therapeutics, Inc. (BTTX) vs ZyVersa Therapeutics, Inc. (ZVSA)

Better Therapeutics, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. ZyVersa Therapeutics, Inc. is the larger, with a market value of $970.0K against $850.0K — 1.1× the size. Across the 8 metrics below, Better Therapeutics, Inc. leads on 6 and ZyVersa Therapeutics, Inc. on 2.

Valuation

Metric BTTX ZVSA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (7,359.20%) (33.15%)
Free cash flow yield 0.00% (1,023.07%) (25.50%)

Profitability

Metric BTTX ZVSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,351.81% 817.13% (56.36%)
Return on assets (162.15%) (225.42%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTTX ZVSA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 45.66% 50.71% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BTTX ZVSA Biotechnology median
Debt to equity (1.44) 0.00 0.00
Current ratio 0.57 0.05 4.72
Net debt to EBITDA 0.02 0.00 0.96

Dividend

Metric BTTX ZVSA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BTTX ZVSA Biotechnology median
Market cap 850.00k 970.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack